Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Sero/subtyping of Neisseria meningitidis isolated from patients in Spain.

Literature DB >> 7925665

Sero/subtyping of Neisseria meningitidis isolated from patients in Spain.

Abstract

To know the types of meningococcal strains in Spain, we serotyped and subtyped 743 Neisseria meningitidis isolates recovered between 1990 and 1992 from patients. A great number of serogroup B, serogroup C and non-groupable meningococci reacted with the serotyping reagents while many serogroup C and non-groupable isolates did not react with the serosubtyping reagents (78.2% and 54.8% respectively); only 8.9% of serogroup B meningococci were non-subtypeable (NST). Distribution of serotypes was similar in serogroup C and in non-groupable strains. Isolates showed great variability in antigenic phenotypes (71 in serogroup B, 20 in serogroup C and 25 in non-groupable meningococci). The most frequent antigenic combinations were 4:P1.15 (39.8%) in serogroup B, 2b:NST (55.8%) in serogroup C and 2b:NST (35.6%) in non-groupable meningococci.

Entities: Disease Species

Mesh：

Year: 1994 PMID： 7925665 PMCID： PMC2271546 DOI： 10.1017/s0950268800051694

Source DB: PubMed Journal: Epidemiol Infect ISSN： 0950-2688 Impact factor: 2.451

10 in total

1. Serotypes of Neisseria meningitidis isolated from patients in Norway during the first six months of 1978.

Authors: E Holten
Journal: J Clin Microbiol Date: 1979-02 Impact factor: 5.948

2. An outbreak of serogroup B:15:P1.16 meningococcal disease, Frederiksborg County, Denmark, 1987-9.

Authors: S Samuelsson; P Ege; L Berthelsen; I Lind
Journal: Epidemiol Infect Date: 1992-02 Impact factor: 2.451

3. Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway.

Authors: G Bjune; E A Høiby; J K Grønnesby; O Arnesen; J H Fredriksen; A Halstensen; E Holten; A K Lindbak; H Nøkleby; E Rosenqvist
Journal: Lancet Date: 1991-11-02 Impact factor: 79.321

4. [Meningococcal meningitis in Spain (1878-1987). VI. Evolution of the proteic subtypes within the serotypes 2 and 15 of Neisseria meningitidis during the epidemic wave].

Authors: F Roman; C Schleissner; M Marin; J A Saez Nieto
Journal: Rev Sanid Hig Publica (Madr) Date: 1990 Mar-Apr

5. Serogroups, serotypes and subtypes of Neisseria meningitidis isolated from patients and carriers in Greece.

Authors: G Tzanakaki; C C Blackwell; J Kremastinou; D M Weir; A Mentis; R J Fallon
Journal: J Med Microbiol Date: 1993-01 Impact factor: 2.472

6. [Meningococcal meningitis in Spain (1978-1980). I. Epidemiologic studies, serogroups and sensitivity to antimicrobial agents].

Authors: J A Sáez Nieto; A Llacer; F Catalá; A Fenoll; J Casal
Journal: Rev Sanid Hig Publica (Madr) Date: 1981 Jul-Aug

7. [Meningococcal meningitis in Spain (1978-1980). II. Serotypes and electrophoretic patterns in polyacrylamide gel].

Authors: J A Sáez Nieto; B Barcia Barrero; C López Galindez; J Casal
Journal: Rev Sanid Hig Publica (Madr) Date: 1981 Nov-Dec

8. Sero- and subtypes of group B meningococci causing invasive infections in Finland in 1976-87.

Authors: H Käyhty; J Poolman; H Abdillahi; A Sivonen; J Eskola; E Tarkka; H Peltola
Journal: Scand J Infect Dis Date: 1989

9. Prevalence of maltose-negative Neisseria meningitidis variants during an epidemic period in Spain.

Authors: J A Sáez-Nieto; A Fenoll; J Vazquez; J Casal
Journal: J Clin Microbiol Date: 1982-01 Impact factor: 5.948

10. Meningococcal disease in The Netherlands, 1958-1990: a steady increase in the incidence since 1982 partially caused by new serotypes and subtypes of Neisseria meningitidis.

Authors: R J Scholten; H A Bijlmer; J T Poolman; B Kuipers; D A Caugant; L Van Alphen; J Dankert; H A Valkenburg
Journal: Clin Infect Dis Date: 1993-02 Impact factor: 9.079

10 in total

5 in total

Sero/subtyping of Neisseria meningitidis isolated from patients in Spain.

1. Serotypes of Neisseria meningitidis isolated from patients in Norway during the first six months of 1978.

2. An outbreak of serogroup B:15:P1.16 meningococcal disease, Frederiksborg County, Denmark, 1987-9.

3. Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway.

4. [Meningococcal meningitis in Spain (1878-1987). VI. Evolution of the proteic subtypes within the serotypes 2 and 15 of Neisseria meningitidis during the epidemic wave].

5. Serogroups, serotypes and subtypes of Neisseria meningitidis isolated from patients and carriers in Greece.

6. [Meningococcal meningitis in Spain (1978-1980). I. Epidemiologic studies, serogroups and sensitivity to antimicrobial agents].

7. [Meningococcal meningitis in Spain (1978-1980). II. Serotypes and electrophoretic patterns in polyacrylamide gel].

8. Sero- and subtypes of group B meningococci causing invasive infections in Finland in 1976-87.

9. Prevalence of maltose-negative Neisseria meningitidis variants during an epidemic period in Spain.

10. Meningococcal disease in The Netherlands, 1958-1990: a steady increase in the incidence since 1982 partially caused by new serotypes and subtypes of Neisseria meningitidis.

1. Increasing incidence of meningococcal disease in Spain associated with a new variant of serogroup C.

2. Isolation of a strain of beta-lactamase-producing Neisseria meningitidis in Spain.

3. Orogenital transmission of Neisseria meningitidis serogroup C confirmed by genotyping techniques.

4. Carriers of Neisseria meningitidis in household contacts of meningococcal disease cases in Catalonia (Spain).

5. Capsule switching among C:2b:P1.2,5 meningococcal epidemic strains after mass immunization campaign, Spain.